Davis Gregory D (CIK 2041855) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-27). Recent activity: Sell SGMO (1,630 shares), Sell SGMO (69,827 shares), Sell SGMO (832 shares), Sell SGMO (5,119 shares), Sell SGMO (7,721 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-27 | SANGAMO THERAPEUTICS, INC (SGMO) | Head of Research & Technology | Sell | 1,630 | $284 |
| 2026-04-23 | SANGAMO THERAPEUTICS, INC (SGMO) | Head of Research & Technology | Sell | 69,827 | $17,694 |
| 2026-02-26 | SANGAMO THERAPEUTICS, INC (SGMO) | Head of Research & Technology | Sell | 832 | $391 |
| 2026-02-26 | SANGAMO THERAPEUTICS, INC (SGMO) | Head of Research & Technology | Sell | 5,119 | $2,406 |
| 2026-01-26 | SANGAMO THERAPEUTICS, INC (SGMO) | Head of Research & Technology | Sell | 7,721 | $3,088 |
| 2025-11-26 | SANGAMO THERAPEUTICS, INC (SGMO) | Head of Research & Technology | Sell | 723 | $304 |
| 2025-10-24 | SANGAMO THERAPEUTICS, INC (SGMO) | Head of Research & Technology | Sell | 6,708 | $4,427 |
| 2025-08-26 | SANGAMO THERAPEUTICS, INC (SGMO) | Head of Research & Technology | Sell | 723 | $427 |
| 2025-07-24 | SANGAMO THERAPEUTICS, INC (SGMO) | Head of Research & Technology | Sell | 6,708 | $3,220 |
| 2025-05-28 | SANGAMO THERAPEUTICS, INC (SGMO) | Head of Research & Technology | Sell | 723 | $340 |
| 2025-04-24 | SANGAMO THERAPEUTICS, INC (SGMO) | Head of Research & Technology | Sell | 6,708 | $5,232 |
Source: SEC Form 4 filings · as of 2026-05-27